A role for immunoglobulin G in donor-specific Streptococcus sanguis-induced platelet aggregation

Thrombosis and Haemostasis

Volumn 95, Issue 2, 2006, Pages 288-293

  McNicol, Archibald ^a   Zhu, Raymond ^a   Pesun, Robert ^a   Pampolina, Caroline ^a   Jackson, Elke C ^a   Bowden, George H W ^a   Zelinski, Teresa ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Fc RIIA; IgG; Platelet; Polymorphisms; Streptococcus sanguis

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G;

ANTIGEN BINDING; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; NORMAL HUMAN; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STREPTOCOCCUS GORDONII; STREPTOCOCCUS SANGUINIS; THROMBOCYTE AGGREGATION;

ANTIGENS, CD; BLOOD DONORS; HUMANS; IMMUNOGLOBULIN G; PLATELET AGGREGATION; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, IGG; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SANGUIS; VASCULAR DISEASES;

EID: 33645534177     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-07-0491     Document Type: Article

References (48)

1. Noll G. Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis 1998; 140: S3-S9.
2. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. Br Med J 1997; 314: 1778-9.
3. Campbell LA, Kuo CC. Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 2003; 18: 48-54.
4. Kuo CC, Shor A, Campbell LA et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 157: 841-9.
5. Neureiter D, Heuschmann P, Stintzing S et al. Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis 2003; 168: 153-62.
6. Vainas T, Kurvers H.A, Mess WH et al. Chlamydia pneumoniae serology is associated with thrombosis-related but not with plaque-related microembolization during carotid endarterectomy. Stroke 2002; 33: 1249-54.
7. Coles KA, Knuiman MW, Plant AJ et al. A prospective study of infection and cardiovascular diseases: the Busselton Health Study. Eur J Cardiovasc Prev Rehabil 2003; 10: 278-82.
8. Haim M, Tanne D, Battler A et al. Chlamydia pneumoniae and future risk in patients with coronary heart disease. Int J Cardiol 2004; 93: 25-30.
9. Ridker PM, Danesh J, Youngman L et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 2001; 135: 184-8.
10. Mayr M, Kiechl S, Mendall MA et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003; 34: 610-5.
11. Zhu J, Quyyumi AA, Muhlestein JB et al. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol 2002; 89: 155-8.
12. Madjid M, Naghavi M, Litovsky S et al. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730-6.
13. Armitage GC. Periodontal infections and cardiovascular disease - how strong is the association? Oral Dis 2000; 6: 335-50.
14. Haynes WG, Stanford C. Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler Thromb Vasc Biol 2003; 23: 1309-11.
15. Ross R. Atherosclerosis - an inflammatory disease. N Eng J Med 2003; 340: 115-26.
16. Tousoulis D, Davies G, Stefanadis C et al. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003; 89: 993-7.
17. Kalvegren H, Majeed M, Bengtsson T. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease? Arterioscler Thromb Vasc Biol 2003; 23: 1677-83.
18. Byrne MF, Kerrigan SW, Corcoran PA et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003; 124: 1846-54.
19. Pham K, Feik D, Hammond BF et al. Aggregation of human platelets by gingipain-R from Porphyromonas gingivalis cells and membrane vesicles. Platelets 2002; 13: 21-30.
20. Herzberg MC, Brintzenhofe KL, Clawson CC. Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun 1983; 39: 1457-69.
21. Erickson PR, Herzberg MC. The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain. J Biol Chem 1993; 268: 1646-9.
22. Herzberg MC, Brintzenhofe KL. ADP-like platelet aggregation activity generated by viridans streptococci incubated with exogenous ATP. Infect Imun 1983; 40: 120-5.
23. Cundell DR, Gerard NP, Gerard C et al. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995; 377: 435-8.
24. Sjöbring U, Ringdahl U, Ruggeri ZM. Induction of platelet thrombi by bacteria and antibodies. Blood 2002; 100: 4470-7.
25. Ford I, Douglas CW, Cox D et al. The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis. Br J Haematol 1997; 97: 737-46.
26. Ford I, Douglas CW, Heath J et al. Evidence for the involvement of complement proteins in platelet aggregation by streptococcus sanguis NCTC 7863. Br J Haematol 1996; 94: 729-39.
27. Kerrigan SW, Douglas I, Wray A et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation Blood 2002; 100: 509-16.
28. 3. Thromb Haemost 2005; 93: 932-9.
29. Herzberg MC. Platelet-streptococcal interactions in endocarditis. Crit Rev Oral Biol Med 996; 7: 222-36.
30. Van der Pol WL, van de Winkel JGJ. IgG receptor polymorphisms: risk factors for disease. Immogenetics 1998; 48: 222-32.
31. Kunicki TJ, Nugent DJ. The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis. Vox Sang 2002; 83: 85-90.
32. Nurden AT. Polyrmorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost 1995; 74: 345-51.
33. Zelinski T, Punter F, McManus K et al. The ELO blood group polymorphism is located in the putative first extracellular loop of human erythrocyte band 3. Vox Sang 1998; 75: 63-5.
34. The Sanger Institute Ensembl Genome Browser. http://www.ensembl.org
35. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction J Intern Med 1989; 225: 293-6.
36. DeStefano F, Anda RF, Kahn HS et al. Dental disease and risk of coronary heart disease and mortality. Br Med J 1993; 306: 688-91.
37. Wu T, Trevisan M, Genco RJ et al. Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Int Med 2000; 160: 2749-55.
38. Genco R, Offenbacher S, Beck J. Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent Assoc 2002; 133: 14S-22S.
39. Hujoel PP. Does chronic periodontitis cause coronary heart disease? A review of the literature. J Am Dent Assoc 2002; 133: 31S-36S.
40. Mealy BL. Influence of periodontal infections on systemic health. Periodontology 2000 1999; 21: 197-209.
41. Clawson CC, White JG. Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors Amer J Pathol 1971; 65: 367-80.
42. Douglas CW, Brown PR, Preston FE. Platelet aggregation by oral streptococci FEMS. Microbiol Lett 1990; 60: 63-7.
43. Sullam PM, Jarvis GA, Valone FH. Role of immunoglobulin G in platelet aggregation by viridans group streptococci. Infect Immun 1988; 56: 2907-11.
44. Moroi M, Jung SM, Yoshida N. Genetic polymorphism of platelet glycoprotein Ib. Blood 1984; 64: 622-9.
45. Murata M, Furihata K, Ishida F et al. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness. Blood 1992; 79: 3086-90.
46. Baker RI, Eikelboom J, Lofthouse E et al. Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001; 98: 36-40.
47. Carlsson LE, Santoso S, Spitzer C et al. The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 1999; 93: 3583-6.
48. Chen J, Dong JF, Sun C et al. Platelet FcγRIIA His131 Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation. J Thromb Haemost 2003; 1: 355-62.